LYEL logo

LYELLyell Immunopharma Inc

$13.28
$0.44
(3.21%)
Overnight
Updated: 11:47 PM EDT·Prev Close $13.72
EarningsAug 14
Mkt Cap$308.48M
Vol142,506.00

About

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
161

Frequently Asked Questions

What is Market Cap of Lyell Immunopharma Inc?
What is the 52-week high for Lyell Immunopharma Inc?
What is the 52-week low for Lyell Immunopharma Inc?
What is Lyell Immunopharma Inc stock price today?
What was Lyell Immunopharma Inc stock price yesterday?
What is the PE ratio of Lyell Immunopharma Inc?
What is the Price-to-Book ratio of Lyell Immunopharma Inc?
What is the 50-day moving average of Lyell Immunopharma Inc?
How many employees does Lyell Immunopharma Inc have?

Advertisement|Remove ads.